SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Protara Therapeutics shares are trading higher after the company announced it has received rare pediatric disease designation for TARA-002 for the treatment of Lymphatic Malformations.

Benzinga · -